US pharmaceutical manufacturer Pfizer's final effort to overthrow a UK court decision invalidating the PDE-5 patent

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.378, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for Strengthening Patent Protection of Pharmaceutical Inventions in Light of Federal Court Decisions

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1929-1936

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical company Pfizer Inc. and the state of Florida, US, have agreed to extend their joint initiative through to September 2005

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 432, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Parallel imports into the UK are seriously affecting Pfizer's

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 359, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

PDE5 Inhibitors and their Applications

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical patent litigation in Europe

By Cook T.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite